Double pituitary adenomas with distinct histological features and immunophenotypes

Por Shimizu, C, Koike, T, Sawamura, Y
Publicado em 2004

Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63

Por Ukaji, F., Kitajima, I., Kubo, T., Shimizu, C., Nakajima, T., Maruyama, I.
Publicado em 1999

CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.

Por Kubo, S, Hasegawa, A, Hashimoto, K, Shimizu, C, Kubo, M, Tada, T, Nakayama, T
Publicado em 1997

Characterization of genome structure of amphotropic and ecotropic wild mouse retroviruses.

Por Lai, M M, Shimizu, C S, Rasheed, S, Pal, B K, Gardner, M B
Publicado em 1982

A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.

Por Shimizu, C, Li, X, Kimura, M, Hashimoto, K, Sugaya, K, Kubo, M, Suzuki, S, Nakayama, T
Publicado em 1998

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

Por Hirata, T, Shimizu, C, Yonemori, K, Hirakawa, A, Kouno, T, Tamura, K, Ando, M, Katsumata, N, Fujiwara, Y
Publicado em 2009

Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin

Por Burns, J C, Song, Y, Bujold, M, Shimizu, C, Kanegaye, J T, Tremoulet, A H, Franco, A
Publicado em 2013

The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma

Por Shinohara, N, Takahashi, M, Kamishima, T, Ikushima, H, Otsuka, N, Ishizu, A, Shimizu, C, Kanayama, H, Nonomura, K
Publicado em 2011

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

Por Tanioka, M, Shimizu, C, Yonemori, K, Yoshimura, K, Tamura, K, Kouno, T, Ando, M, Katsumata, N, Tsuda, H, Kinoshita, T, Fujiwara, Y
Publicado em 2010

Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Por Taniyama, T.K., Hashimoto, K., Katsumata, N., Hirakawa, A., Yonemori, K., Yunokawa, M., Shimizu, C., Tamura, K., Ando, M., Fujiwara, Y.
Publicado em 2014

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

Por Yonemori, K, Ando, M, Yunokawa, M, Hirata, T, Kouno, T, Shimizu, C, Tamura, K, Katsumata, N, Hirakawa, A, Matsumoto, K, Yamanaka, Y, Arioka, H, Fujiwara, Y
Publicado em 2009

Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease

Por Burns, JC, Shimizu, C, Shike, H, Newburger, JW, Sundel, RP, Baker, AL, Matsubara, T, Ishikawa, Y, Brophy, VA, Cheng, S, Grow, MA, Steiner, LL, Kono, N, Cantor, RM
Publicado em 2005

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies

Por Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K
Publicado no Br J Cancer (2016)

Human Coronavirus-NL63 Infection is not Associated with Acute Kawasaki Disease

Por Baker, S. C., Shimizu, C., Shike, H., Garcia, F., van der Hoek, L., Kuijper, T. W., Reed, S. L., Rowley, A. H., Shulman, S. T., Talbot, H. K. B., Williams, J. V., Burns, J. C.
Publicado em 2006